🇦🇺 Australia Country × Condition
chronic kidney disease Clinical Trials in Australia
Active clinical trials for chronic kidney disease with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: EARLY_Phase 1, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT07577817 EARLY_Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
Enrollment
72 pts
Country
🇦🇺 Australia
Cajal Therapeutics Inc.
View Trial → NCT07615985 Phase 1
Recruiting
Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016
Enrollment
30 pts
Country
🇦🇺 Australia
Pulmongene Ltd.
View Trial → NCT07231679 Phase 1, Phase 2
Recruiting
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Enrollment
94 pts
Country
🇦🇺 Australia
Ingenia Therapeutics INC
View Trial → NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Enrollment
465 pts
Country
🇦🇺 Australia
Novo Nordisk A/S
View Trial → Frequently Asked Questions
How many chronic kidney disease clinical trials are active in Australia?
There are currently 4 active clinical trials for chronic kidney disease with sites in Australia, of which 4 are actively recruiting patients.
How can I join a chronic kidney disease clinical trial in Australia?
To join a chronic kidney disease clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are chronic kidney disease trials in Australia?
Active chronic kidney disease trials in Australia span EARLY_Phase 1, Phase 1, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology